Cheniere Energy, Inc. · LNG · FY2025 Q4 · Calendar Q1 2026
Cheniere enters 2026 with record output, steady guidance and execution risks
The call supports a constructive operating outlook through record 2025 output, substantial long-term contract coverage, and continued capacity additions. That case depends on completing major projects on schedule and managing lower spot margins, costs, and gas-supply constraints.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about LNG FY2025 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter account, management now reports a completed record 2025, sets 2026 EBITDA and distributable cash flow ranges, and says first LNG production at Train 5 was achieved ahead of schedule. The prior quarter had emphasized the production outlook and progress across Corpus Christi Stage 3; the current analysis highlights ongoing execution and brownfield expansion work.
Guidance delta
Maintained 2026 adjusted EBITDA guidance of $6.75–$7.25 billion and distributable cash flow guidance of $4.35–$4.85 billion. Management cited lower spot margins alongside higher contracted volumes.
Key takeaways
- Management said 2025 set records with 670 LNG cargoes and $6.94 billion in adjusted EBITDA, above guidance.
- More than 95% of LNG capacity is contracted through 2030, supporting cash-flow visibility, while 2026 guidance was maintained.
- First LNG production at Stage 3 Train 5 was achieved ahead of schedule; additional Stage 3 and brownfield projects remain in progress.
- Reported EPS exceeded consensus, while reported revenue was below consensus.
Management priorities
- Complete Stage 3 Trains 5–7 and bring additional capacity online in 2026.
- Advance Sabine Pass and Corpus Christi brownfield expansions toward final investment decisions.
- Continue securing long-term sales agreements and execute the stated capital-return program.
Follow LNG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Nov 2, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 30, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 30, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Oct 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 30, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 23, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Sep 10, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 24, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 11, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 7, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 2, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 24, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Mar 23, 2026 |
| B of A Securities | Buy | Buy | Maintain | Mar 20, 2026 |
| UBS | Buy | Buy | Maintain | Mar 3, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 14, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Oct 24, 2025 |
| Mizuho | Outperform | Outperform | Maintain | Aug 29, 2025 |
| Stifel | Buy | Buy | Maintain | Apr 22, 2025 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 20, 2023 |
| CFRA | Hold | Hold | Maintain | May 1, 2020 |
| Bank of America | Buy | Buy | Maintain | May 8, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 7, 2018 |
| Scotia Howard Weil | Sector Outperform | Sector Perform | Upgrade | Jun 14, 2016 |
| Credit Suisse | Neutral | Outperform | Downgrade | Apr 3, 2014 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 2, 2014 |
| BTIG Research | Buy | Buy | Maintain | Nov 18, 2013 |
| BTIG | Buy | Buy | Maintain | Nov 18, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $330.32. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Raymond James | Analyst unavailable | $340 | $287.84 | +2.9% | Oct 19, 2026 |
| Scotiabank | Analyst unavailable | $311 | $278.59 | -5.8% | Oct 15, 2026 |
| Jefferies | Emma Schwartz | $336 | $278.18 | +1.7% | Oct 10, 2026 |
| Barclays | Analyst unavailable | $287 | $275.26 | -13.1% | Oct 7, 2026 |
| Scotiabank | Analyst unavailable | $312 | $279.48 | -5.5% | Sep 10, 2026 |
| RBC Capital | Elvira Scotto | $319 | $277.45 | -3.4% | Aug 24, 2026 |
| Argus Research | Analyst unavailable | $330 | $274.24 | -0.1% | Aug 18, 2026 |
| Morgan Stanley | Devin McDermott | $310 | $263.17 | -6.2% | Aug 7, 2026 |
| Barclays | Analyst unavailable | $279 | $265.77 | -15.5% | Aug 7, 2026 |
| Barclays | Theresa Chen | $274 | $265.03 | -17.1% | Jul 15, 2026 |
| Bernstein | Analyst unavailable | $283 | $230.86 | -14.3% | Jun 16, 2026 |
| Wolfe Research | Keith Stanley | $300 | $227.88 | -9.2% | Jun 2, 2026 |
| UBS | Analyst unavailable | $290 | $241.98 | -12.2% | May 13, 2026 |
| Scotiabank | Analyst unavailable | $288 | $263.26 | -12.8% | Apr 16, 2026 |
| UBS | Manav Gupta | $340 | $291.4 | +2.9% | Mar 26, 2026 |
| UBS | Manav Gupta | $301 | $252.64 | -8.9% | Mar 3, 2026 |
| Morgan Stanley | Devin McDermott | $236 | $223.35 | -28.6% | Feb 24, 2026 |
| Jefferies | Analyst unavailable | $251 | $207.35 | -24.0% | Jan 25, 2026 |
| Scotiabank | Brandon Bingham | $266 | $206.72 | -19.5% | Jan 16, 2026 |
| Barclays | Theresa Chen | $259 | $199.72 | -21.6% | Jan 15, 2026 |
| Wolfe Research | Analyst unavailable | $220 | $193.69 | -33.4% | Jan 14, 2026 |
| BMO Capital | Ameet Thakkar | $254 | $189.28 | -23.1% | Dec 17, 2025 |
| Goldman Sachs | John Mackay | $275 | $212 | -16.7% | Nov 3, 2025 |
| Jefferies | Analyst unavailable | $290 | $211.52 | -12.2% | Oct 30, 2025 |
| Raymond James | Analyst unavailable | $278 | $222.24 | -15.8% | Oct 24, 2025 |
| Mizuho Securities | Analyst unavailable | $273 | $242.14 | -17.4% | Aug 29, 2025 |
| Scotiabank | Brandon Bingham | $261 | $236.96 | -21.0% | Jul 15, 2025 |
| Jefferies | Sam Burwell | $288 | $236.32 | -12.8% | Jun 26, 2025 |
| Wells Fargo | Michael Blum | $267 | $236.32 | -19.2% | Jun 25, 2025 |
| UBS | Manav Gupta | $277 | $223.39 | -16.1% | Mar 18, 2025 |
| Argus Research | Analyst unavailable | $255 | $224.03 | -22.8% | Mar 18, 2025 |
| Morgan Stanley | Devin McDermott | $255 | $223.65 | -22.8% | Jan 31, 2025 |
| Mizuho Securities | Robert Mosca | $214 | $183.58 | -35.2% | Oct 29, 2024 |
| Bank of America Securities | Jean Ann Salisbury | $215 | $182.58 | -34.9% | Oct 17, 2024 |
| Barclays | Theresa Chen | $202 | $188.77 | -38.8% | Oct 15, 2024 |
| Bernstein | Bob Brackett | $217 | $167.62 | -34.3% | Jun 24, 2024 |
| Stifel Nicolaus | Benjamin Nolan | $208 | $157.54 | -37.0% | May 6, 2024 |
| Redburn Partners | Peter Low | $162 | $154.43 | -51.0% | Apr 16, 2024 |
| Mizuho Securities | Robert Mosca | $187 | $149.16 | -43.4% | Jun 22, 2023 |
| Barclays | Analyst unavailable | $192 | $153.47 | -41.9% | Jan 13, 2023 |
| Citigroup | Analyst unavailable | $190 | $143.49 | -42.5% | Jan 9, 2023 |
| Citigroup | Analyst unavailable | $205 | $163.1 | -37.9% | Dec 9, 2022 |
| Wells Fargo | Analyst unavailable | $162 | $138.4 | -51.0% | Apr 28, 2022 |
| Raymond James | Analyst unavailable | $165 | $139.26 | -50.0% | Apr 20, 2022 |
| Wolfe Research | Steve Fleishman | $151 | $129.25 | -54.3% | Feb 25, 2022 |
| Mizuho Securities | Robert Mosca | $145 | $129.25 | -56.1% | Feb 25, 2022 |
| Cowen & Co. | Jason Gabelman | $145 | $129.25 | -56.1% | Feb 25, 2022 |
| UBS | Shneur Gershuni | $145 | $104.83 | -56.1% | Jan 24, 2022 |
| Wells Fargo | Michael Blum | $123 | $100.57 | -62.8% | Dec 16, 2021 |
| J.P. Morgan | Jeremy Tonet | $133 | $104.64 | -59.7% | Oct 22, 2021 |
| Citigroup | Timm Schneider | $115 | $89.44 | -65.2% | Sep 8, 2021 |
Track every rating change on LNG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCheniere Energy, Inc. is an energy infrastructure firm predominantly focused on liquefied natural gas (LNG) related activities within the United States. The company owns and operates two significant LNG terminals: one in Sabine Pass, located in Cameron Parish, Louisiana, and another near Corpus Christi, Texas. Beyond its terminals, Cheniere also owns the 94-mile Creole Trail pipeline, which serves to connect the Sabine Pass LNG Terminal with various interstate and intrastate pipelines. It further manages the 21.5-mile Corpus Christi pipeline, ensuring the Corpus Christi LNG terminal is linked to a diverse network of natural gas pipelines, both within and across state lines. The company also participates in the marketing of LNG and natural gas. Cheniere Energy, Inc. was established in 1983 and has its corporate headquarters in Houston, Texas.
Historical context
All LNG earningsEnergy peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CVX Chevron Corporation | FY2026 Q3 · Calendar Q4 2026 | +8.4% | +1.8% | Chevron posts strong Q3 as production, cash flow and AI value rise |
| XOM Exxonmobil Holdings Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.7% | +2.2% | ExxonMobil Highlights Refining, LNG and Cash Returns in Q3 |
| IMO Imperial Oil Limited | FY2026 Q3 · Calendar Q4 2026 | +6.4% | +5.5% | Imperial Oil: downstream strength and low-carbon growth lead Q3 |
| CCJ Cameco Corporation | FY2026 Q3 · Calendar Q4 2026 | -101.4% | -7.9% | Cameco keeps nuclear-growth thesis intact as Key Lake outage weighs |
| BP BP p.l.c. | FY2026 Q3 · Calendar Q4 2026 | +22.6% | +0.1% | BP Q3: Strong profit, lower debt, safety risks persist |
| FSLR First Solar, Inc. | FY2026 Q3 · Calendar Q4 2026 | +13.5% | -1.4% | First Solar: Margin gains offset lower volume outlook |
Latest beats and misses
Who reports nextBeat on EPS
- CHDFY2026 Q3 · October 30, 2026+2.2% EPS+1.2% move
- AZNFY2026 Q3 · October 30, 2026+7.3% EPS+7.0% move
- FRTFY2026 Q3 · October 30, 2026+3.9% EPS-1.1% move
- CVXFY2026 Q3 · October 30, 2026+8.4% EPS+1.8% move
- BTSGFY2026 Q3 · October 30, 2026+14.2% EPS+11.1% move
- EXCFY2026 Q3 · October 30, 2026+10.4% EPS+0.5% move
Missed on EPS
- GLPIFY2026 Q3 · October 29, 2026-11.5% EPS-1.3% move
- LYBFY2026 Q3 · October 30, 2026-1.2% EPS+5.0% move
- CCJFY2026 Q3 · October 30, 2026-101.4% EPS-7.9% move
- VALEFY2026 Q3 · October 29, 2026-24.6% EPS+1.9% move
- DLR-PLFY2026 Q3 · October 29, 2026-8.4% EPS— move
- DLR-PKFY2026 Q3 · October 29, 2026-8.4% EPS— move
Get the LNG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-11-02T09:40:45.660244+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-02T09:40:45.657457+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-02. For educational purposes only; not investment advice.